WHO Suspends Study of Hydroxychloroquine as COVID-19 Treatment to Review Safety Concerns
Updated: May 25, 2020 10:20 PM EDT | Originally published: May 25, 2020 3:19 PM EDT
In a press briefing, WHO director-general Tedros Adhanom Ghebreyesus said that in light of a paper published last week in the Lancet that showed people taking hydroxychloroquine were at higher risk of death and heart problems, there would be “a temporary pause” on the hydroxychloroquine arm of its global clinical trial.
Tedros said the executive group behind WHO’s global “Solidarity” trial met on Saturday and decided to conduct a comprehensive review of all available data on hydroxychloroquine and that its use in the trial would be suspended for now. “We’re just acting on an abundance of caution based on the recent results of all the studies to to ensure that we can continue safely with that arm of the trial,” he said. WHO said it expected to have more details within the next two weeks.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concernsThe World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
続きを読む »
WHO temporarily halts trial of hydroxychloroquine over safety concernsThe group wants to 'be proactive, err on the side of caution' when it comes to the malaria drug's use in treating COVID-19.
続きを読む »
WHO pauses hydroxychloroquine trial amid safety concerns day after Trump says he stopped taking controversial medicineThe trial pause comes the day after the president revealed he was no longer taking the unproven coronavirus treatment and prevention method that health experts and officials—including within the Trump administration—have warned not to use.
続きを読む »
WHO pauses trial of hydroxychloroquine as coronavirus treatment amid safety concernsHydroxychloroquine, which Trump has repeatedly touted as a potential game changer in fighting the coronavirus, is an anti-malarial drug that's also used by doctors to treat rheumatoid arthritis and lupus.
続きを読む »
WHO drops hydroxychloroquine from global study of experimental COVID-19 treatmentsThe World Health Organization said that it will temporarily drop hydroxychloroquine — the malaria drug U.S. President Trump has said he is taking — from its...
続きを読む »
WHO temporarily pauses studying hydroxychloroquine due to safety concernsThe coronavirus pandemic has brought countries to a standstill. Here's the latest updates on Covid-19 cases, deaths, government responses and more.
続きを読む »